基于器官功能障碍轨迹的脓毒症亚表型
研究在四个不同ICU队列的脓毒症患者中构建72小时SOFA评分轨迹,用动态时间规整(DTW)计算轨迹相似性、层次凝聚聚类(HAC)识别亚表型,并在三个验证队列中复现。开发队列识别出快速恶化型(n=612,13.1%)、延迟恶化型(n=960,20.5%)、快速改善型(n=1932,41.3%)和延迟改善型(n=1174,25.1%)四种亚表型。快速恶化型院内死亡率最高(28.3%,P值<0.001),尽管其入ICU时SOFA均值(4.5)低于快速改善型(死亡率5.5%,SOFA均值5.5)。随机森林模型预测亚表型的总体准确率在入ICU后6小时为0.78(95%CI,[0.77,0.8]),24小时升至0.87(95%CI,[0.86,0.88])。多数脓毒症患者为改善型且死亡风险较低,但因人数众多仍占全部死亡的20%以上。
要点
- 开发队列4678例脓毒症患者中识别出四种SOFA轨迹亚表型:快速恶化型13.1%、延迟恶化型20.5%、快速改善型41.3%、延迟改善型25.1%。
- 快速恶化型院内死亡率最高(28.3%,P值<0.001),但其入ICU时SOFA均值4.5低于快速改善型(死亡率5.5%,SOFA均值5.5)。
- 快速恶化型特征为合并症负担更高、酸中毒和内脏器官功能障碍;快速改善型特征为使用血管加压药但无酸中毒。
- 随机森林模型预测亚表型准确率入ICU后6小时为0.78(95%CI,[0.77,0.8]),24小时为0.87(95%CI,[0.86,0.88])。
- 改善型患者死亡风险较低但人数众多,占全部死亡的20%以上;轨迹亚表型对临床试验的效能和预测性富集有直接意义。
适用人群与场景
- 四个不同ICU队列的脓毒症患者,开发队列4678例,三个验证队列分别为3665例、12282例和4804例。
诊断标准与关键阈值
- 基于72小时SOFA评分轨迹,使用动态时间规整(DTW)计算轨迹相似性、层次凝聚聚类(HAC)识别亚表型。
研究设计与关键结果
- 研究类型为多队列轨迹聚类分析,开发队列4678例脓毒症患者,三个验证队列分别为3665例、12282例和4804例。
- 开发队列识别四种亚表型:快速恶化型(n=612,13.1%)、延迟恶化型(n=960,20.5%)、快速改善型(n=1932,41.3%)、延迟改善型(n=1174,25.1%)。
- 快速恶化型院内死亡率最高(28.3%,P值<0.001),入ICU时SOFA均值4.5;快速改善型死亡率5.5%,SOFA均值5.5。
- 随机森林模型预测亚表型总体准确率入ICU后6小时为0.78(95%CI,[0.77,0.8]),24小时为0.87(95%CI,[0.86,0.88])。
- 三个验证队列中复现了相似的亚表型。
- 多数脓毒症患者为改善型且死亡风险较低,但因人数众多仍占全部死亡的20%以上。
证据类型、等级与局限
- 证据类型为多队列聚类分析研究,亚表型在三个验证队列中复现,并用替代聚类方法进行了敏感性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,识别基于轨迹的亚表型对临床试验的效能和预测性富集有直接意义。
- 作者认为,理解这些不同轨迹的病理生理学可能揭示未预料到的治疗靶点,并为临床试验确定更精确的人群和终点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Sepsis is a heterogeneous syndrome, and the identification of clinical subphenotypes is essential. Although organ dysfunction is a defining element of sepsis, subphenotypes of differential trajectory are not well studied. We sought to identify distinct Sequential Organ Failure Assessment (SOFA) score trajectory-based subphenotypes in sepsis.
METHODS: We created 72-h SOFA score trajectories in patients with sepsis from four diverse intensive care unit (ICU) cohorts. We then used dynamic time warping (DTW) to compute heterogeneous SOFA trajectory similarities and hierarchical agglomerative clustering (HAC) to identify trajectory-based subphenotypes. Patient characteristics were compared between subphenotypes and a random forest model was developed to predict subphenotype membership at 6 and 24 h after being admitted to the ICU. The model was tested on three validation cohorts. Sensitivity analyses were performed with alternative clustering methodologies.
RESULTS: A total of 4678, 3665, 12,282, and 4804 unique sepsis patients were included in development and three validation cohorts, respectively. Four subphenotypes were identified in the development cohort: Rapidly Worsening (n = 612, 13.1%), Delayed Worsening (n = 960, 20.5%), Rapidly Improving (n = 1932, 41.3%), and Delayed Improving (n = 1174, 25.1%). Baseline characteristics, including the pattern of organ dysfunction, varied between subphenotypes. Rapidly Worsening was defined by a higher comorbidity burden, acidosis, and visceral organ dysfunction. Rapidly Improving was defined by vasopressor use without acidosis. Outcomes differed across the subphenotypes, Rapidly Worsening had the highest in-hospital mortality (28.3%, P-value < 0.001), despite a lower SOFA (mean: 4.5) at ICU admission compared to Rapidly Improving (mortality:5.5%, mean SOFA: 5.5). An overall prediction accuracy of 0.78 (95% CI, [0.77, 0.8]) was obtained at 6 h after ICU admission, which increased to 0.87 (95% CI, [0.86, 0.88]) at 24 h. Similar subphenotypes were replicated in three validation cohorts. The majority of patients with sepsis have an improving phenotype with a lower mortality risk; however, they make up over 20% of all deaths due to their larger numbers.
CONCLUSIONS: Four novel, clinically-defined, trajectory-based sepsis subphenotypes were identified and validated. Identifying trajectory-based subphenotypes has immediate implications for the powering and predictive enrichment of clinical trials. Understanding the pathophysiology of these differential trajectories may reveal unanticipated therapeutic targets and identify more precise populations and endpoints for clinical trials.
参考来源
- Xu Z, Mao C, Su C, et al. Sepsis subphenotyping based on organ dysfunction trajectory. Crit Care. 2022. PMID: 35786445. doi:10.1186/s13054-022-04071-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。